Latest insights from our experts
Clinical trial to improve prevention of group B Strep infection
A major clinical trial has been funded by the National Institute for Health Research to see if prevention of early-onset group B Strep infections in babies can be improved.
With reference to this news article from Group B Strep Support, GBS specialist Stuart Bramley writes –
“This is a wonderful development and well done to GBSS. It is extraordinary how the UK still relies on a risk-based approach to Strep B, which clearly isn’t working given the number of babies who contract this infection, often with devastating outcomes. A particularly telling statistic is that 65% of babies with Group B Strep are born to mothers with no risk factors. Those countries who routinely test all pregnant women have found reductions in the number of babies being harmed and children in this country deserve nothing less.
I sincerely hope that this initiative leads to all mums-to-be being tested. Given the figures highlighted by GBSS, how can this not be happening already?”